BPA Call HT001424A0002-HT001425F0019
Award Date
3/21/25
Potential Completion Date
3/21/25
Potential Value
$249K
Federal Agency
Defense Health Agency
Awardee
Sofie CO.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Health Agency (DHA) awarded a Blanket Purchase Agreement (BPA) call contract worth $197,174.40 to Sofie CO., doing business as Sofie, for the provision of various radiopharmaceuticals. The contract has a firm fixed price pricing type and an ultimate completion date of September 30, 2025. Sofie CO. is a subsidiary of Sofie Biosciences, Inc. that specializes in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals,...
This federal contract award to Sofie CO., doing business as Sofie, is for the supply of radiopharmaceuticals required for patient care. The $10,826.16 Firm Fixed Price contract, awarded by the Defense Health Agency (DHA), is a Blanket Purchase Agreement (BPA) call that runs through September 30, 2024. Sofie is an established provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to various federal agencies, including the Department of Veterans...
This is a federal contract awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as Sofie, for the delivery of radiopharmaceuticals. The contract, valued at $36,087.20, is a Blanket Purchase Agreement (BPA) Call with a firm fixed price. The contract has a completion date of September 30, 2024. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals, to various...
This federal contract award, valued at $25,261.04, was granted to Sofie CO. (doing business as Sofie) by the Defense Health Agency (DHA) to provide radiopharmaceuticals needed for prostate cancer patients with metastatic lesions. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type and an ultimate completion date of September 30, 2025. Sofie is a subsidiary of Sofie Biosciences, Inc., specializing in the development and delivery of molecular diagnostics...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The $10,826.16 contract is for the supply of a radiopharmaceutical needed for prostate cancer patients with metastatic lesions after definitive treatment. The contract has an ultimate completion date of September 30, 2024. Sofie is a specialized provider of radiopharmaceuticals, pharmaceuticals, and...
This is a definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Sofie CO. for the provision of radiopharmaceuticals. The contract has a firm fixed price and a potential value of $1,765,046.64, with a completion date of April 12, 2024. Sofie CO. is a for-profit organization and the parent company is Sofie Biosciences, Inc. The company has extensive experience in PET imaging and has received numerous federal contract awards from the VA, Defense...
Sofie Co., a subsidiary of Sofie Biosciences, Inc., has been awarded a $13,984 firm fixed price call against the Defense Health Agency's Basic Purchasing Agreement to provide radiopharmaceutical doses for diagnostic imaging procedures. Under this contract, Sofie will deliver the requested pharmaceutical products to support imaging services at facilities located in Sterling, Virginia, with all work to be completed by September 30, 2022. No set-aside provisions were applied to this award to...
This is a federal contract award to Sofie CO., doing business as Sofie, for the provision of PET radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract, valued at $77,670.00, is a firm fixed-price purchase order with a completion date of September 30, 2018. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, particularly PET imaging agents and cancer treatment products. The contract...
This is a federal contract award to Sofie CO., doing business as Sofie, to provide nuclear medicine medications. The contract has a ceiling value of $75,000.00 and was awarded by the Defense Health Agency (DHA), a component of the Department of Defense. The contract is a Blanket Purchase Agreement (BPA) call and is for firm fixed-price products. Sofie CO. is a subsidiary of Sofie Biosciences, Inc. and specializes in developing and delivering molecular diagnostics and therapeutics, including...
Sofie Co., a subsidiary of Sofie Biosciences, Inc., has been awarded a $20,976 firm fixed price call against the Defense Health Agency's Basic Pricing Agreement for radiopharmaceuticals. The contract has no set-aside designation and requires delivery of the requested pharmaceutical products to locations in Sterling, Virginia through September 2023. As the DHA works to ensure service members and their families have access to quality healthcare, this contract will support their efforts to...